ATLASAIM ImmunoTech (AIM) earnings date: Nov 16, 2026
AIM ImmunoTech (AIM) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 16, 2026. Analysts expect EPS of -$0.09.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AIM
| Last price | $0.16 (+7.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.0% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the AIM ImmunoTech stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
AIM ImmunoTech reports on Nov 16, 2026. One email the day before, with ATLAS’s read on AIM ImmunoTech. You can switch it off at any time.
Alert me before AIM reportsFree to start. Creating an account takes under a minute.
Notify me when AIM ImmunoTech reports
Track AIM free Add AIM ImmunoTech to a free ATLAS watchlist and see its next report date in one place.
AIM earnings at a glance
| Next report (confirmed) | Mon, Nov 16, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.09 |
| Last report | Aug 7, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -79.0% |
| Average move around a report | ±43.4% (last 4) |
| Sector | Healthcare · Biotechnology |
AIM ImmunoTech earnings history: last 4 reports
AIM ImmunoTech last reported on Aug 7, 2026: EPS of -$0.43 against an estimate of -$0.12 (-258.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$0.12 | -$0.43 | -258.3% | Miss | -2.6% |
| Jul 30, 2026 | $2.51 | $2.62 | +4.4% | Beat | +5.7% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | +106.4% |
| May 15, 2026 | -$0.37 | -$0.69 | -86.5% | Miss | +58.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AIM
See the fair value, the probability range and the earnings history of AIM ImmunoTech on its ATLAS page.
AIM ImmunoTech (AIM) stock analysisPlans from €3.99 a month.
AIM ImmunoTech earnings: frequently asked questions
When does AIM ImmunoTech (AIM) report earnings?
AIM ImmunoTech is scheduled to report on Monday, November 16, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AIM?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.09 per share (USD). Estimates can change before the report.
How often does AIM beat earnings estimates?
Of its last 4 reports with a recorded result, AIM ImmunoTech beat the EPS estimate 2 times; the average surprise was -79.0%. Past results do not predict the next one.
How much does AIM move around earnings?
Over its last 4 reports the stock moved an average of 43.4% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did AIM ImmunoTech beat earnings estimates last quarter?
AIM ImmunoTech last reported on Aug 7, 2026: EPS of -$0.43 against an estimate of -$0.12 (-258.3% surprise), a miss.
How much does AIM usually move in a day?
On a normal trading day the ATLAS model puts AIM’s one-day range at about ±4.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 16, 2026
Educational information, not investment advice. Disclaimer